Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Drug Therapy

Drug Therapy

The advent of drug therapy has profoundly shaped modern mental health care, providing targeted treatments for a range of psychological disorders. Psychotherapeutic drugs, classified into antianxiety, antidepressant, and antipsychotic medications, address symptoms across anxiety disorders, mood disorders, and schizophrenia. While these medications have transformed patient outcomes, they require careful management due to their potential side effects and limitations.
Antianxiety Medications

Psychosis: Goals of Pharmacotherapy

Psychosis: Goals of Pharmacotherapy

Antipsychotic drugs are a crucial treatment method for acute and chronic psychoses, bipolar illness, and behavioral disorders. The selection of these drugs depends on several factors, including the state of the disease, clinical judgment, possible drug interactions, and the patient's sensitivity to adverse effects. In immediate scenarios, such as delirium and dementia, short-term treatment with low doses of high-potency typical or atypical agents can effectively manage symptom exacerbation. For...

Psychosis and Antipsychotic Drugs: Overview

Psychosis and Antipsychotic Drugs: Overview

The term "psychosis" refers to a spectrum of mental disorders characterized by abnormal thoughts, perceptions, and behaviors. It can manifest as mood disorders, dementia, delirium with psychotic features, substance-induced psychosis with psychotic features, brief psychotic disorder, delusional disorder, schizoaffective disorder, and schizophrenia. Among all these disorders, schizophrenia is the most common psychotic disorder, affecting 1% of the worldwide population. Psychotic symptoms in all...

Psychological and Sociocultural Causes of Schizophrenia

Psychological and Sociocultural Causes of Schizophrenia

Schizophrenia, a complex psychiatric disorder, has been historically misunderstood. Early psychological theories attributed its origins to childhood trauma and unresponsive parenting. However, contemporary research largely rejects these notions, favoring the vulnerability-stress hypothesis. This model proposes that individuals with a genetic predisposition to schizophrenia may develop the disorder following exposure to significant environmental stressors. Notably, studies on high-risk...

Treatment Strategies for Psychological Disorders

Treatment Strategies for Psychological Disorders

Treatment approaches for psychological disorders fall into three main categories: psychological, biological, and sociocultural. Each approach targets different aspects of mental health, requiring varying levels of education and training.
Psychological therapies focus on modifying emotions, thoughts, and behaviors through talking, interpreting, listening, rewarding, challenging, and modeling. Clinical psychologists, counselors, and social workers commonly practice psychotherapy. Clinical...

Antidepressant Drugs: MAOIs and Other Agents

Antidepressant Drugs: MAOIs and Other Agents

Atypical antidepressants, including bupropion (Wellbutrin), mirtazapine (Remeron), nefazodone (Serzone), trazodone (Desyrel), and vilazodone (Viibryd), offer unique mechanisms of action. Bupropion weakly inhibits dopamine and norepinephrine reuptake, aiding depression treatment and smoking cessation, with a low risk of sexual dysfunction. Mirtazapine enhances serotonin and norepinephrine neurotransmission, leading to sedation, increased appetite, and weight gain. As a result, it helps treat...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Changes in insight and outcome over the early course of first-episode psychosis. The OPTiMiSE trial.

Schizophrenia research. Cognition·2026

Same author

Aetiological factors in functional seizures and functional motor symptoms: shared and distinct features.

Journal of neurology, neurosurgery, and psychiatry·2026

Same author

Increased Brain-Age Gap in Young Adults With Psychotic Experiences.

Biological psychiatry global open science·2026

Same author

Cognition and metacognition in functional motor symptoms and functional seizures: a case-control study.

Psychological medicine·2026

Same author

The association between childhood Toxoplasma gondii, psychotic experiences and grey matter volume: A population-based cohort study.

Schizophrenia research·2026

Same author

Insight, the law and psychiatry: Going round in circles or playing nice?

International journal of law and psychiatry·2026

Same journal

Effectiveness and safety of repeat dose subcutaneous ketamine for treatment-resistant depression, and the impact of prior ketamine treatment: open label extension of the KADS study.

The British journal of psychiatry : the journal of mental science·2026

Same journal

Definitional invisibility: when institutional language reframes identity as choice.

The British journal of psychiatry : the journal of mental science·2026

Same journal

Potential implications of removing evidence of impairment from the DSM-5 age-of-onset criterion in adult ADHD assessment.

The British journal of psychiatry : the journal of mental science·2026

Same journal

The pressurised leaky funnel: rethinking recruitment, selection and retention in the UK psychiatry workforce.

The British journal of psychiatry : the journal of mental science·2026

Same journal

Cutting through stigma: psychiatry and neurosurgery working together.

The British journal of psychiatry : the journal of mental science·2026

Same journal

A fourth pillar for evidence-based medicine: implications for psychiatry - CORRIGENDUM.

The British journal of psychiatry : the journal of mental science·2026

See all related articles

Search research articles

Related Experiment Videos

Treatment adherence in psychoses.

Anthony S David

The British Journal of Psychiatry : the Journal of Mental Science

|December 2, 2010

Summary

This summary is machine-generated.

An intervention improved treatment adherence in psychosis patients, leading to better self-reported adherence and fewer hospital readmissions. Addressing partial adherence is crucial for effective psychosis treatment.

Related Experiment Videos

Area of Science:

Psychiatry
Clinical Psychology
Pharmacology

Background:

Partial adherence to treatment is a significant barrier in managing psychosis.
Existing guidelines for treatment adherence require updates to reflect current evidence.

Discussion:

A randomized controlled trial demonstrated that a specific intervention positively impacts treatment adherence in individuals with psychosis.
The intervention showed benefits in both patient-reported and clinician-observed adherence measures.

Key Insights:

The intervention led to a trend towards reduced hospital readmissions for psychosis patients.
Improved adherence is directly linked to better treatment outcomes and reduced healthcare utilization.

Outlook:

Further research should explore long-term adherence benefits and cost-effectiveness.
Updated clinical guidelines are needed to incorporate effective adherence interventions for psychosis.